Leg pain – dermatological causes

Abstract

Introduction Vascular diseases are often suspected of being the cause of acute or chronic leg pain. However, the question also arises as to whether dermatological conditions may be associated with leg pain.

Methods Dermatological conditions are systematically presented with respect to concomitant or causal painfulness.

Results Pain is prominent with infections of the skin, while allergic or toxic contact dermatitis, pruritic diseases, and cutaneous autoimmune diseases are associated with pain.

Conclusions An underlying dermatological condition should be considered whenever there is leg pain of unknown origin. Pain may occur as a prodromal symptom of herpes zoster (shingles).

Key words

pain - lower limbs - skin

• Literatur / References

• 1 Stynes S, Konstantinou K, Dunn KM. Classification of patients with low back-related leg pain: a systematic review. BMC Musculoskelet Disord 2016; 17: 226
• 2 Jendoubi F, Rohde M, Prinz JC. Intracellular Streptococcal Uptake and Persistence: A Potential Cause of Erysipelas Recurrence. Front Med (Lausanne) 2019; 6: 6 Published 2019 Jan 29, doi:10.3389/fmed.2019.00006
• 3 McNamara DR, Tleyjeh IM, Berbari EF. et al. A predictive model of recurrent lower extremity cellulitis in a population-based cohort. Arch Intern Med 2007; 167 (07) 709-715
• 4 Pavlotsky F, Amrani S, Trau H. Recurrent erysipelas: risk factors. J Deutschen Dermatol Gesellschaft 2004; 2: 89-95
• 5 Cox NH. Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up. Br J Dermatol 2006; 155: 947-950
• 6 Bjornsdottir S, Gottfredsson M, Thorisdottir AS. et al. Risk factors for acute cellulitis of the lower limb: a prospective case-control study. Clin Infect Dis 2005; 41: 1416-1422
• 7 Abrego MO, Saba JES, Halliburton C. et al. Fasciitis and Streptococcal Toxic-shock Syndrome: The Importance of Early Diagnosis and Surgical Management. J Orthop Case Rep 2018; 8 (05) 57-60 DOI: 10.13107/jocr.2250–0685.1212
• 8 Guerreiro de Moura CA, de Assis LH, Góes P. et al. A Case of Acute Generalized Pustular Psoriasis of von Zumbusch Triggered by Hypocalcemia. Case Rep Dermatol 2015; 7: 345-351 Published 2015 Dec 3 DOI: 10.1159/000442380
• 9 Klemke CD, Booken N, Weiss C. et al. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases. Br J Dermatol 2015; 173: 93-105
• 10 Maintz L, Bieber T, Novak N. Die verschiedenen Gesichter der Histaminintoleranz: Konsequenzen für die Praxis. Dtsch Arztebl 2006; 103 (51/52) A 3477-3483
• 11 Schmelz M. Neurophysiologie des Juckreizes. Aktuelle Dermatologie 2013; 39: 218-222
• 12 Pereira 1 MP, Agelopoulos K, Köllner J. et al. Selective Nerve Fibre Activation in Patients with Chronic Generalized Pruritus May Indicate a Central Sensitization Mechanism. Acta Derm Venereol. 2019 [Epub ahead of print]
• 13 Dumont S, Péchère M ,, Toutous Trellu L. Chronische Prurigo: eine ungewöhnliche Manifestation des Hodgkin-Lymphoms. Karger Kompass Dermatol 2018; 6: 227-229
• 14 S2k Leitlinie: Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei ErwachsenenAWMF-Registernummer 082–006, aktualisiert 2. Januar 2019.
• 15 Maurer M, Zuberbier T, Siebenhaar F. et al. Chronische Urtikaria – Was bringt die neue Leitlinie?. J Deutsch Ges Dermatol 2018; 16: 585-595
• 16 Werner RN. et al. European consensus-based (S2k) guideline on the management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), part 2: treatment. J Eur Acad Dermatol Venereol 2017; 31 (01) 20-29
• 17 World Health Organization. Cancer pain relief: with a guide to opioid availability. 2nd ed.. Geneva: World Health Organization; 1996
• 18 Lemmenmeier E, Gaus B, Schmid P. et al. A case of erythrodermia from exacerbated psoriasis vulgaris due to treatment of acute hepatitis C. BMC Dermatol 2016; 16 (01) 5 Published 2016 May 26 DOI: 10.1186/s12895–016–0042–5